Comparison of the boronic acid disk potentiation test and cefepime-clavulanic acid method for the detection of ESBL among AmpC-producing Enterobacteriaceae

Indian Journal of Medical Microbiology

Volumn 29, Issue 3, 2011, Pages 297-301

  Shoorashetty, R M ^a   Nagarathnamma, T ^b   Prathibha, J ^b  

^a PONDICHERRY INSTITUTE OF MEDICAL SCIENCES   (India)

^b Victoria Hospital   (India)

Author keywords

AmpC lactamase; boronic acid; cefepime; Enterobacteriaceae; Extended spectrum lactamase

Indexed keywords

BETA LACTAMASE AMPC; BORONIC ACID DERIVATIVE; CEFEPIME; CEFOTAXIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; DISK DIFFUSION; DISK POTENTIATION TEST; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; NONHUMAN; PHENOTYPIC CONFIRMATORY TEST;

EID: 80052629638     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.83917     Document Type: Article

References (23)

1. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother 1995;39:1211-33.
2. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: A clinical update. Clin Microbiol Rev 2005;18:657-86.
3. Bradford PA. Extended spectrum lactamases in 21st century: Characterization, epidemiology and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-51. (Pubitemid 32979636)
4. Jacoby GA. AmpC -Lactamases. Clin Microbiol Rev 2009;22:161-82.
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 17 th informational supplement. CLSI document M100-S17. Wayne, PA: CLSI; 2007.
6. Black JA, Thomson KS, Pitout JD. Use of β-lactamase inhibitors in disk tests to detect plasmid mediated ampC β-lactamases. J Clin Microbiol 2004;42:2203-6. (Pubitemid 38637842)
7. Black JA, Moland ES, Thomson KS. AmpC disk test for detection of plasmid-mediated ampC β-lactamases in Enterobacteriaceae lacking chromosomal ampC β-lactamases. J Clin Microbiol 2005;43:3110-3. (Pubitemid 40981309)
8. Yagi T, Wachino J, Kurokawa H, Suzuki S, Yamane K, Doi Y, et al. Practical methods using Boronic acid compounds for identification of class C β-lactamase producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 2005;43:2551-8. (Pubitemid 40827918)
9. Nasim K, Elsayed S, Pitout JD, Conly J, Church DL, Gregson DB. New method for laboratory detection of ampC β-lactamases in Escherichia coli and Klebsiella pneumoniae. J Clin Microbiol 2004;42:4799-802. (Pubitemid 39362406)
10. Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC betaβ-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a Veterans medical center. J Clin Microbiol 2000;38:1791-6. (Pubitemid 30253917)
11. Manchanda V, Singh NP. Occurrence and detection of AmpC β-lactamases among gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur hospital, Delhi, India. J Antimicrob Chemother 2003;51:415-8. (Pubitemid 36231167)
12. Shahid M, Malik A, Agarwal M, Singhal S. Phenotypic detection of extended-spectrum and AmpC β-lactamases by a new spot-inoculation method and modified three-dimensional extract test: Comparison with conventional three-dimensional extract test. J Antimicrob Chemother 2004;54:684-7. (Pubitemid 39263912)
13. Singhal S, Mathur T, Khan S, Upadhyay DJ, Chugh S, Gaind R, et al0. Evaluation of methods for AmpC β-lactamases in gram negative clinical isolates from tertiary care hospitals. Indian J Med Microbiol 2005;23:120-4. (Pubitemid 40712521)
14. Beesley T, Gascoyne N, Knott-Hunziker V, Petursson S, Waley SG, Jaurin B, et al. The inhibition of class C β-lactamases by Boronic acids. Biochem J 1983;209:229-33. (Pubitemid 13153654)
15. Tondi D, Cal S, Shoichet BK, Costi MP. Structural study of phenyl boronic acid derivatives as AmpC β-lactamase inhibitors. Bioorg Med Chem Lett 2010;20:3416-9.
16. Coudron PE. Inhibitor-based methods for detection of plasmid-mediated AmpC β-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J Clin Microbiol 2005;43:4163-7. (Pubitemid 41129715)
17. Song W, Bae IK, Lee Y, Lee C, Lee SH, Jeong Sh. Detection of Extended-spectrum β-lactamases by using Boronic acid as an AmpC β-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J Clin Microbiol 2007;45:1180-4. (Pubitemid 46626482)
18. Song W, Jeong SH, Kim JS, Kim HS, Shin DH, Roh KH et al. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC β-lactamases and extended-spectrum β-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis. Diagn Microbiol Infect Dis 2007;57:315-8. (Pubitemid 46330652)
19. Jeong SH, Song W, Park MJ, Kim JS, Kim HS, Bae IK, et al. Boronic acid disk tests for identification of extended-spectrum β-lactamase production in clinical isolates of Enterobacteriaceae producing chromosomal AmpC β-lactamases. Int J Antimicrob Agents 2008;31:467-71.
20. Derbyshire H, Kay G, Evans K, Vaughan C, Kavuri U, Winstanley T. A simple disc diffusion method for detecting AmpC and extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae. J Antimicrob Chemother 2009;63:497-501.
21. Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB, et al. Epidemiology and clinical features of bloodstream infections caused by AmpC-type β-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2004;48:3720-8. (Pubitemid 39304595)
22. Ananthan S, Subha A. Cefoxitin resistance mediated by loss of a porin in clinical strains of Klebsiella pneumoniae and Escherichia coli. Indian J Med Microbiol 2005;23:20-3. (Pubitemid 40347428)
23. Sturenburg E, Sobottka I, Noor D, Laufs R, Mack D. Evaluation of a new cefepime-CA ESBL Etest to detect extended-spectrum β-lactamases in an Enterobacteriaceae strain collection. J Antimicrob Chemother 2004;54:134-8. (Pubitemid 39028980)